Patel Naimish

CIK 00020216792 companiesANTWERPEN

SEC Profile

Transactions

Companies

Filings

CIK

0002021679

Recent Transactions

21 trades

Award
Agomab Therapeutics NV$AGMB
Stock Option (Right to Buy)
2026-09-11+56,328→ 56,328 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-05-29+22,000→ 22,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-05-29$55.62/sh−3,786→ 19,357 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-05-28−10,000→ 20,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-05-28+10,000→ 23,143 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-03-20+30,000→ 30,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-03-20+38,499→ 38,499 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-16$48.26/sh−3,150→ 13,143 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-14+8,125→ 16,293 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-03-14−8,125→ 24,375 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-10-03+16,500→ 16,500 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-05-30+25,000→ 25,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-05-29$35.94/sh−3,932→ 6,068 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-05-28−10,000→ 30,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-05-28+10,000→ 10,000 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-04-03$32.96/sh+1,508→ 1,508 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-14+32,500→ 32,500 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-03-14+46,667→ 46,667 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-10-16+18,333→ 18,333 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-05-28+40,000→ 40,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-05-28+85,000→ 85,000 total

Companies

Recent Filings

Address

AGOMAB THERAPEUTICS NV POSTHOFLEI 1/6

ANTWERPEN, 2600

View on SEC.gov